# FDA 483 - David R. Hassman, DO - July 18, 2014

Source: https://www.keypedia.com/records/483/david-r-hassman-do/84a07a88-449a-4909-9db7-4cc57edd2a74

> FDA 483 for David R. Hassman, DO on July 18, 2014. Product: drugs. Access full analysis and detailed observations.

---

## Details

- Record Type: 483
- Company Name: David R. Hassman, DO
- Inspection Date: 2014-07-18
- Product Type: drugs
- Office Name: New Jersey District Office
- Summary: An FDA inspection of David R. Hassman, D. O., Principal Investigator, in Berlin, NJ, identified a significant deviation from the investigational plan. The firm failed to conduct the study in accordance with the protocol, specifically regarding the timing of audiology assessments and various study visits. This non-compliance impacts the integrity of the clinical trial data for Protocols HYD3002 and HYD3003.

## Related Officers

- [Loretta Nemchik](https://www.keypedia.com/people/loretta-nemchik/37791f6d-862a-4863-9295-1cca43f9fe3a)

Company: https://www.keypedia.com/companies/david-r-hassman-do/9b4de0fb-3926-4c3e-93d4-3d0f2a2d8e9d

Office: https://www.keypedia.com/offices/new-jersey-district-office/6ff5e2e9-5cff-44c7-af24-5a55329a8248